Drug Detail:Influenza virus vaccine, h5n1 (H5n1 influenza virus vaccine [ in-floo-en-za-vye-rus-vax-een ])
Drug Class: Viral vaccines
Two 0.5 mL doses, intramuscularly, given 21 days apart
6 months to 17 years:
Two 0.25 mL doses, intramuscularly, given 21 days apart
Data not available
Data not available
Safety and efficacy have not been established in patients younger than 6 months.
To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov
Consult WARNINGS section for additional precautions.
Data not available
Administration advice: